Inhibition of apoptosis by downregulation of hBex1, a novel mechanism, contributes to the chemoresistance of Bcr/Abl+ leukemic cells (Q39912919)

15 September 2017

Inhibition of apoptosis by downregulation of hBex1, a novel mechanism, contributes to the chemoresistance of Bcr/Abl+ leukemic cells (English)

1 reference

15 September 2017

0 references

1 reference

Kefeng Ding

1

1 reference

15 September 2017

Yanyan Su

2

1 reference

15 September 2017

Lingrong Pang

3

1 reference

15 September 2017

Qinghua Lu

4

1 reference

15 September 2017

Zhanhuai Wang

5

1 reference

15 September 2017

Suzhan Zhang

6

1 reference

15 September 2017

Shu Zheng

7

1 reference

15 September 2017

Jianshan Mao

8

1 reference

15 September 2017

Yongliang Zhu

9

1 reference

15 September 2017

language of work or name

English

0 references

publication date

21 November 2008

1 reference

15 September 2017

1 reference

15 September 2017

30

1 reference

15 September 2017

1

1 reference

15 September 2017

35-42

1 reference

Synergistic activity of imatinib and 17-AAG in imatinib-resistant CML cells overexpressing BCR-ABL--Inhibition of P-glycoprotein function by 17-AAG.

15 September 2017

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN251

High frequency of point mutations clustered within the adenosine triphosphate-binding region of BCR/ABL in patients with chronic myeloid leukemia or Ph-positive acute lymphoblastic leukemia who develop imatinib (STI571) resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN251

Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-kappaB control

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN251

Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN251

Neoadjuvant, adjuvant and palliative treatment of gastrointestinal stromal tumours (GIST) with imatinib: a centre-based study of 17 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN251

Primitive, quiescent and difficult to kill: the role of non-proliferating stem cells in chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN251

Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN251

BCR-ABL gene mutations in relation to clinical resistance of Philadelphia-chromosome-positive leukaemia to STI571: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN251

Multiple BCR-ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (STI571) in chronic phase and blast crisis chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN251

Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN251

A Bcr/Abl-independent, Lyn-dependent form of imatinib mesylate (STI-571) resistance is associated with altered expression of Bcl-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN251

Roles of Bim in apoptosis of normal and Bcr-Abl-expressing hematopoietic progenitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN251

Analysis of Gene Expression Profiles in an Imatinib‐Resistant Cell Line, KCL22/SR

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN251

BCR/ABL kinase inhibition by imatinib mesylate enhances MAP kinase activity in chronic myelogenous leukemia CD34+ cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN251

Heat shock protein 90 inhibition in imatinib-resistant gastrointestinal stromal tumor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN251

Overexpression of P-glycoprotein in K562 cells does not confer resistance to the growth inhibitory effects of imatinib (STI571) in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN251

MDR1 gene overexpression confers resistance to imatinib mesylate in leukemia cell line models

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN251

Transformed immortalized gastric epithelial cells by virulence factor CagA of Helicobacter pylori through Erk mitogen-activated protein kinase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN251

Bim and Bad mediate imatinib-induced killing of Bcr/Abl+ leukemic cells, and resistance due to their loss is overcome by a BH3 mimetic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN251

Characterization of the Bex gene family in humans, mice, and rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN251

Epigenetic silencing of TCEAL7 (Bex4) in ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN251

Structure-function analysis of NADE: identification of regions that mediate nerve growth factor-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN251

Genome-wide analysis of epigenetic silencing identifies BEX1 and BEX2 as candidate tumor suppressor genes in malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN251

Bex1, a novel interactor of the p75 neurotrophin receptor, links neurotrophin signaling to the cell cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN251

NADE, a p75NTR-associated cell death executor, is involved in signal transduction mediated by the common neurotrophin receptor p75NTR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN251

Characterization of the c-Jun N-terminal kinase-BimEL signaling pathway in neuronal apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN251

Cadherins in development: cell adhesion, sorting, and tissue morphogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN251

Functional epigenetics identifies a protocadherin PCDH10 as a candidate tumor suppressor for nasopharyngeal, esophageal and multiple other carcinomas with frequent methylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN251

21 January 2018

Identifiers

DOI

10.1093/CARCIN/BGN251

1 reference

release_zpypatnyzndbjpuxhkqehg3ciq

15 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/zpypatnyzndbjpuxhkqehg3ciq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference